Schedule 13D ownership disclosure
EKIMAS Corp
Security class unavailable · CUSIP: 28265K205
Event date: 2024-11-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 30.8100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-24-049436
- Form type
- SC 13D
- Filer
- Alteral Therapeutics ApS
- CIK
- CIK 2026040
- Filed
- Dec 10, 2024
- Reporting period
- Nov 12, 2024
- Description
- Schedule 13D beneficial ownership